PCWG3
Showing 426 - 434 of 434
Prostate Cancer Metastatic Trial in Worldwide (EMD 525797, Placebo, Standard of Care (SoC))
Completed
- Prostate Cancer Metastatic
- EMD 525797
- +2 more
-
Pleasant Hill, California
- +70 more
Nov 9, 2015
Prostatic Tumors Trial in Trento (Docetaxel, Prednisone, Enzalutamide)
Unknown status
- Prostatic Neoplasms
- Docetaxel
- +2 more
-
Trento, ItalySanta Chiara Hospital
May 22, 2015
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- linsitinib
- laboratory biomarker analysis
-
Cleveland, Ohio
- +1 more
Mar 2, 2015
Castration-resistant Prostate Cancer, Advanced Breast Cancer Trial in Nagoya-city, Kobe-city, Chuo-ku (LFA102)
Completed
- Castration-resistant Prostate Cancer, Advanced Breast Cancer
-
Nagoya-city, Aichi, Japan
- +2 more
Nov 9, 2014
Metastatic Castrate-Resistant Prostate Cancer (mCRPC),, Efficacy,, Safety and Tolerability, Trial in United Kingdom, United
Completed
- Metastatic Castrate-Resistant Prostate Cancer (mCRPC),
- +5 more
- Intermittent dosing of AZD5363
-
Sarasota, Florida
- +7 more
Jun 18, 2014
Prostate Cancer Trial in Durham, Norfolk (Temsirolimus, Diphenhydramine)
Terminated
- Prostate Cancer
-
Durham, North Carolina
- +1 more
Jan 24, 2014